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Background: Cervical cancer is one of the leading causes of cancer death among women worldwide, with more
than 85% of cases occurring in low- and middle-income countries. Human papillomavirus (HPV) screening allows
for self-collection with the potential to increase coverage, but still requires triage to identify which HPV+ women
need diagnostic and treatment procedures. However, achieving high levels of triage adherence can be challenging,
especially among socially vulnerable women. This paper describes the ATICA protocol (Application of Communication
and Information Technologies to Self-Collection, for its initials in Spanish), aimed at evaluating the implementation
strategy and the effectiveness of a multi-component mobile health (mHealth) intervention to increase adherence to
triage among women with HPV+ self-collected tests.
Methods: We will use an effectiveness-implementation hybrid type I trial with a mixed-methods evaluation approach.
A cluster randomized trial design including 200 community health workers (CHWs) will evaluate whether the mHealth
intervention increases adherence to triage among HPV+ women who self-collected at home during a CHW visit within
120 days after a positive result. The intervention includes an initial mobile phone text message (SMS) alert
and subsequent reminders sent to HPV+ women. For those who do not adhere to triage within 60 days of a
positive HPV test, an email and SMS will be sent to the CHWs to promote contact with these women during
home visits.
We will use the Consolidated Framework for Implementation Research (CFIR) as an organizing and analytic
framework to evaluate the implementation of the intervention while also drawing on Reach, Effectiveness,
Adoption, Implementation, and Maintenance (RE-AIM). We will conduct a self-administered, semi-structured
survey of CHWs, semi-structured interviews with local health authorities, and a survey of HPV+ women.
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Combining both qualitative and quantitative data will provide rich insights into local implementation
challenges and successes.
Discussion: Findings from the implementation evaluation will be applicable to programs that use or are
planning to incorporate HPV self-collection and/or mHealth interventions in different settings and countries.
This innovative study will also serve as a model for using implementation science in the region.
Trial registration: ClinicalTrials.gov, NCT03478397. Registered on 20 March 2018.
Keywords: mHealth, Self-collection, HPV, Community health workers, ImplementationBackground
Cervical cancer (CC) is one of the leading causes of cancer
death among women from low- and middle-income coun-
tries (LMIC), where 85% of worldwide CC cases occur [1].
Human papillomavirus (HPV) DNA testing is a highly
effective screening method [2] and allows women to self-
collect samples [3, 4], dramatically reducing barriers to
screening. In a self-collection screening program, triage of
abnormal screening results is a key step in identifying
HPV+ women who will need further diagnostic and treat-
ment procedures. While several triage methods are avail-
able for detecting precancerous lesions, cytology has been
validated in several randomized trials and is part of the
screening policy of several European and Latin American
countries (LAC) [5]. Cytology involves HPV+ women at-
tending health centers for triage to determine appropriate
follow-up. However, adherence to triage and treatment is
a widespread problem for CC programs in Latin America
[6], especially among women who are not regular health
system users [7]. Efficacious interventions aimed at im-
proving adherence to triage are needed.
In Argentina, one of the first countries in the world to
implement HPV testing as the primary screening method
[8], adherence to triage of HPV+ women with self-collected
tests is a challenge [9]. During the first year of program-
matic scaling-up of self-collection in the province of Jujuy,
triage was 30% in the 4 months after screening. After a sig-
nificant effort by community health workers (CHWs) to
contact women at their homes, adherence increased to 77%
by 12months [9]. Studies that have analyzed adherence to
different follow-up steps after abnormal cytology [10–12]
show that one of the key issues is the delivery of test results.
In a study carried out in Argentina, not receiving results
was one of the most reported barriers to follow-up by
women who were not adherent to diagnosis and treatment
after a positive Papanicolaou (Pap) result [12]. However,
home visits by CHWs to all HPV+ women as a public
health strategy is difficult to sustain as a high proportion of
all screened women would need to be contacted (around
13%) [8]. A mobile health (mHealth) intervention has
the potential to increase triage adherence among HPV+
women without being heavily dependent on scarce
human resources.Using mobile phone text messages (SMS messages) as
reminders has proven to be effective in a variety of set-
tings and for different health problems (e.g., noncommu-
nicable diseases and AIDS [13–18]). SMS messages are
useful for reminding patients about medication adherence
(e.g., antiretroviral therapy and asthma treatment [13–15]),
and to improve preventive and outpatient clinic attendance
rates in many LMIC [16–19]. Similarly, mHealth tools tar-
geted at providers, including CHWs, improve the quality of
services they provide, most prominently through decision
support and reminders [20–23]. SMS messages have ad-
vantages over other reminder systems, including that they
can be sent to providers and patients and require less staff
[13, 18]. SMS messages can enhance the link between
patients and health services and increase adherence in
primary care and gynecology care settings via re-
minders, counseling, or by addressing patient appre-
hensions [13, 16–18].
In this paper, we present the protocol of the ATICA
study (Application of Information and Communication
Technologies to Self-collection, for its initials in Spanish).
This effectiveness-implementation hybrid type I trial aims
to develop, test, and evaluate the implementation of an
innovative multi-component mHealth intervention: SMS
messages to women testing positive after HPV self-
collection, and automated reminders to CHWs to visit
and encourage HPV+ women who have not completed
triage to attend health centers.
The proposed study is innovative by combining
mHealth technologies with a personal contact with
CHWs to increase adherence to triage of HPV+ women.
There is increasing recognition that progress in complex
health problems will come from integration of techno-
logical advances and social innovations [24]. A previous
study carried out by our team to evaluate the effective-
ness of self-collection offered by CHWs to increase
screening uptake, the EMA (Evaluation of Self-collection
Modality, for its initial in Spanish) study [25], showed
that an integrated approach with synergy between two
innovations, HPV self-collection and CHW work
reorganization, can result in a real difference in CC con-
trol [25]. In the EMA study, women mentioned that the
form and content of the messages transmitted by CHWs
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of self-collection [26]. Similarly, we expect that a
multi-component intervention combining mHealth tech-
nologies with the work of CHWs will improve adherence
to follow-up care, increase the effectiveness of the




The specific aims of the study are:
1. To evaluate the effectiveness of a multi-component
mHealth intervention to increase adherence to triage
among women with HPV+ self-collected tests
compared with usual care. We aim to increase
adherence to triage of HPV+ women through SMS
messages to HPV+ women, and automated
reminders to CHWs to alert them to visit HPV+
women who have not responded to reminders and
encourage follow-up.
2. To evaluate the implementation strategy and
identify barriers and facilitators to implementation
of the multi-component mHealth intervention.
The study design will follow the structure of an
effectiveness-implementation hybrid type I trial [27] and
will use a mixed-methods approach [28, 29]. We will use a
hybrid type I design as proposed by Curran and colleagues
[27] to galvanize the translation of efficacious treatments
to enhance their public health impact. This hybrid design
is appropriate for the proposed intervention because the
following conditions are met: it has strong face validity
that will support applicability to a new setting or popula-
tion, there is at least indirect evidence for the intervention
that will support applicability to a new setting or popu-
lation, and there is minimal risk associated with the inter-
vention [27].
We combine a cluster randomized trial to evaluate the
effectiveness of a multi-component mHealth interven-
tion with a mixed-methods approach involving quantita-
tive and qualitative evaluations of the implementation
using the Reach, Effectiveness, Adoption, Implementa-
tion and Maintenance (RE-AIM) [30] and Consolidated
Framework for Implementation Research (CFIR) [31]
frameworks. The mixed-methods design will allow a
deep understanding of the reasons for success or failure
of the mHealth intervention and also quantify the inter-
vention impact on the outcomes [32]. ATICA will in-
tegrate quantitative and qualitative methods in multiple
ways: a) formative research with women to develop the
framing and content of SMS messages; b) a pragmatic
cluster randomized trial to measure the effectiveness of
the intervention in improving triage adherence amongHPV+ women; and c) the acceptability of the strategy will
be measured during the post-intervention phase through
1) a quantitative survey among CHWs, 2) semi-structured
interviews with health authorities and health professionals,
and 3) interviews with HPV+ women using a structured
questionnaire to gather reasons for triage adherence/
nonadherence.
We will use the RE-AIM [30] and CFIR [31] frameworks
at all stages of the research process. The RE-AIM frame-
work is particularly appropriate to assess the public health
impact of interventions [30], and the CFIR is useful to sys-
tematically assess contextual factors that influence imple-
mentation and adoption [31].
Hypothesis
Following the Health Belief Model [33, 34], we anticipate
that the SMS messages will serve as specific cues to action
and stimulate triage behavior. The CHW visit will be an
additional cue to action to nonresponders, as well as an
opportunity to provide counseling and support which will
change women’s perceived benefits of and barriers to
screening, as well as the perceived threat of CC. We expect
both of these components to increase adherence to triage
in the intervention group.
Setting
The research will take place in the province of Jujuy,
located in northwest Argentina (Jujuy total population:
673,307; women: 51%; urban population: 85% [35]). The
rate of mobile phone penetration was 82% of urban
households in 2011, though this percentage has probably
increased [36]. The CC mortality rate in Jujuy is 10.6 per
100,000 women (2012–2014). The public health sector
in Argentina includes a network of public hospitals and
primary health care (PHC) centers which mostly provide
care to people not covered by the social security sector
(informal economy workers and unemployed people).
For the uninsured, health services are provided free of
cost. In Jujuy, the PHC system integrates approximately
700 paid full-time CHWs who twice yearly visit approxi-
mately 110,000 households for health-related tasks such
as immunization and promoting maternal and child
health. HPV testing was introduced in 2012 through the
Jujuy Demonstration Project [8]; since then, it has
become the primary screening test and is available to all
women aged 30 and over at public health institutions.
The provincial program on CC prevention uses the
national screening information system (SITAM, for its
initials in Spanish) [37]. SITAM registers all screening,
diagnosis, and treatment events of women screened in
the public health system and works as an online medical
record. Results of HPV tests and Pap smears are imme-
diately registered in SITAM to generate a diagnosis
form, which is instantly available to providers at public
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2014, HPV self-collection is available and offered during
the CHW routine home visits, and those women who
accept the offer perform self-collection at home. Women
who opt for self-collection are instructed to go to the
health center within 30 days to pick up the results. In
2014 and 2015, approximately 38% of all women aged
30 years and over who were screened through the public
health sector did it through self-collection [38].
Intervention development
Formative research
A minimum of four focus groups discussions (FGD) will
be carried out to explore women’s opinions about how
to frame SMS messages and their content. All FGDs will
have 6–12 women stratified by age (30–50 and 51 or
more years old) and location (urban/rural). Participants
will be recruited by CHWs during routine health rounds,
a recruitment strategy which we have used and found to
be effective [26]. CHWs and participants who partici-
pated in the formative research will not be eligible to
take part in the cluster randomized trial. With prior
authorization of the participants, each FGD will be
audio-recorded to facilitate further analysis. We will use
both audio and textual transcripts for the analysis. The
Health Belief Model will guide our qualitative analysis to
help identify and operationalize the responses and reac-
tions of women to SMS messages, allowing us to also
identify perceived benefits and barriers to triage as well
as cues to action [33, 34]. Feedback from FGDs will be
used to develop SMS messages which will be validated
and pilot tested.
Development of the automated messaging system (AMS)
We will develop an AMS to send SMS messages and
e-mails. The AMS will connect with SITAM to identify
women to whom the SMS messages will be sent.
SMS message validation and pilot test
The validation process will include a sample with at least
10 women aged 30 years old or above. Women will be
recruited in public PHC centers and will be asked to
provided signed informed consent. They will receive the
SMS proposed for the intervention to their phones and
then trained interviewers will administer an ad-hoc indi-
vidual questionnaire using face-to-face interaction. The
questionnaire will include open- and closed-ended ques-
tions. The design of the questionnaire will follow the
procedures and purposes of cognitive interviews, adap-
ting the instruments used by other researchers [39, 40].
Different techniques will be combined to evaluate the
validity of contents and procedures, and thus ensure that
participants understand the instructions and respond in
the same way using similar criteria [41–43].After the validation process, we will carry out a pilot
test. Five CHWs (not included in the sample) will be
recruited and trained. During their routine home visits,
they will invite eligible women to participate in the
study. Upon registration of HPV test results into the
SITAM database, the AMS will send the corresponding
messages. We will then carry out telephone interviews
using the ad-hoc questionnaire to test the reception of
SMS messages, and the perception of women regarding
its content and objective.
Cluster-randomized trial
Participants
CHW eligibility All CHWs (clusters) of the Jujuy pro-
vince who offer self-collection and have a minimum of
26 potentially eligible women to participate in the study
will be eligible (approximately 500).
Women eligibility All women living in a house visited
by a selected CHW will be invited to participate if they
satisfy the following inclusion criteria:
1) aged 30 years or older;
2) have performed HPV self-collection offered by
CHWs during the current routine home visit;
3) are competent enough to understand the
consent form;
4) are able to communicate with CHWs;
5) are able to provide a mobile phone number.
Intervention
Women with positive self-collected tests will receive a
multi-component intervention (Fig. 1). Upon registration
in SITAM of the HPV result at the laboratory, they will
receive a weekly SMS message for 4 weeks, notifying
them that the test results are available and that they
should go to the health center. Messages will be stopped
if a Pap result is registered in SITAM.
In addition, CHWs will receive an e-mail and SMS
message sent through the AMS to visit those HPV+
women who, at 60 days since the HPV result, have not
attended triage. CHWs will visit nonadherent HPV+
women within 15 days of being notified for an in-person
reminder and will provide counseling about the impor-
tance of triage. The subgroup of HPV+ women visited
by CHWs are given 30 days to attend health centers for
triage. This timeline is in agreement with the screening
protocol of the provincial screening program.
Negative HPV women will receive one SMS message
stating that results are available at the health center.
Women with HPV+ self-collected tests participating in
the control group will receive usual care as described in
the Settings section.
Fig. 1 Flow diagram of the mHealth intervention. CHW community health worker, HPV human papillomavirus
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provincial laboratory (average time 15 days between
smear collection and report) and the results input into
SITAM.
Figure 2 offers a CONSORT flow diagram depicting
trial procedures, Fig. 3 shows the schedule of enrolment,
interventions, and assessments [44], and Table 1 shows
the timeline of the ATICA project. The protocol presen-
tation also follows the SPIRIT 2013 checklist [44]
(Additional file 1).
Outcome measures
The primary outcome of the trial is the percentage of HPV+
women with triage 120 days after the HPV result has been
uploaded to SITAM, which measures the overall effect of
the multi-component intervention (i.e., SMS message sent
to women and SMS message and e-mail sent to CHWs to
visit women with no triage at day 60). The secondary out-
come is the percentage of HPV+ women with triage 60 days
after HPV test results have been uploaded to SITAM, which
measures the individual effect of the SMS messages sent to
women (before CHWs receive prompts to visit nonadherent
HPV+ women).
Sample size and power considerations
We expect to collect information on approximately 400
HPV+ women (240 in the mHealth (MH) group and 160
in the usual care (UC) group). For the primary outcome
(triage percentage at 120 days), the target sample size
will have 97% power to detect a 20% absolute differencebetween the two groups when the UC group has a 30%
triage (two-sided test, alpha = 0.05, intraclass correlation
coefficient (ICC) 0.10). For the secondary outcome (tri-
age percentage at 60 days) under the same assumptions,
the proposed sample size will have 90% power to detect
a 10% absolute difference between groups when the UC
group has a 15% triage by day 60.
Power calculations were performed with PASS version
14 under very conservative assumptions: 1) the average
number of HPV+ women per CHW was two (in fact,
from the EMA trial [25] for CHWs with 13 or more
women with self-collected tests, the average number of
positive women was 4.1); and 2) an ICC of 0.10.
CHW and women recruitment
CHWs will be randomly selected and invited to partici-
pate in the study by the research team. All women living
in households visited by a participating CHW satisfying
the eligibility criteria will be invited to participate in the
study during their routine home visits.
For the MH group, once women have performed HPV
self-collection, CHWs will screen for eligibility criteria,
including the use of a mobile phone. If the woman does
not have a personal phone, she will be asked if she is
willing to be contacted and receive SMS messages on a
shared phone. Consent to participate will also mean that
women agree to be contacted via SMS messages, even if
phones are shared by several family members, and
potentially in person again by the CHW. CHWs will
explain the sequence and content of SMS messages, how
Fig. 2 Flowchart of the ATICA cluster randomized trial. CHW community health worker
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messages, and that they might come back for a personal
visit if they do not complete triage.
For the UC group, once women agree to participate in
the study, CHWs will provide UC counseling using routine
programmatic materials [45, 46] and information using
standard provincial protocol and materials. They will
inform women that they should go to the health center
within a month to get their HPV test results.Randomization
After classifying them into four groups according to gen-
der and urban/rural setting, a stratified sample of 240
CHWs will be randomly selected with allocation propor-
tional to strata. We expect a minimum of 200 will be
enrolled. Enrolled CHWs will be randomly allocated to
the MH or the UC group (3:2 ratio) using a computer-
generated random number list generated by the study
statistician. Allocation concealment is guaranteed because
Fig. 3 Schedule of enrolment, interventions, and assessments for the ATICA study. CHW community health worker, HPV human papillomavirus
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time. Blinding of intervention and outcome assessments is
not feasible due to the characteristics of the study.
The number of CHWs to be recruited was defined based
on pragmatic considerations (120 CHWs in the MH group
and 80 CHWs in the UC group). From our experience [25],
this is a feasible number of CHWs that can be enrolled and
trained in programmatic/routine conditions. We allocated a
larger number of CHWs to the MH group to benefit the
assessment of the implementation outcomes.
Based on PHC records and previous experience [25],
we estimate that each CHW will enroll an average of 20
eligible women in a 10-month period. Thus, the unit of
randomization is the CHW and the unit of observation
is the woman.
We assumed an attrition rate of 20% for women due to
problems with mobile phones (i.e., nonidentified number,
unpaid phone bill, lack of signal, etc.), SMS messages not
delivered, and/or other issues. Under a 13% prevalence ofHPV+ in this population [8], we estimate that each CHWs
will contribute an average of two HPV+ women.
Data collection
CHWs from both groups will use a specific form (Trial
form) to collect data about women’s sociodemographic
characteristics, inclusion/exclusion criteria, and tasks per-
formed by the CHWs. Eligible women who do not agree to
participate will be asked basic sociodemographic data (age,
health insurance, education level, and reason for refusal) to
allow comparison of enrolled and non-enrolled women.
Data on HPV testing, triage, diagnosis, and treatment
will be imported from SITAM, where records will be
linked through the ID number of women.
Data analysis
All analysis will be conducted on an intention-to-treat
(ITT) basis; the effect of the multi-component mHealth
intervention on the primary outcome will be assessed
Table 1 Timeline of ATICA Study
AMS automated messaging system, CHW community health worker
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model (logit link and binomial distribution) will include
the trial group as a fixed effect and CHWs as the clus-
tering variable. Potential effect modifications due to the
rural/urban location of the woman and CHW gender
will be evaluated. Baseline sociodemographic characte-
ristics of the women will be compared between groups
using the same model with link and distribution selected
depending on the variable. Factors showing clear un-
balance between arms will be included in the model pro-
posed above to adjust for potential confounding. The
same approach will be used to estimate the intervention
effect on the secondary outcome.
Analyses will be conducted using STATA 14.0 or
SAS v.9.4.
Safety and monitoring
All SMS messages and e-mails will comply with security
procedures according to NIH Human Protection Subject
Guidelines [47]. The Principal Investigator (PI) will be
responsible for monitoring adverse events and data qua-
lity and safety since this is a low-risk investigation. The
plan for monitoring data quality and accuracy will
include the following: data entry from the cluster ran-
domized trial (CRT) will be performed through specific
software that will include range and inter-item
consistency checks. Entries outside of the expected
range will not be permitted. Re-entry of 20% of ques-
tionnaires will be performed for quality control. The
data cleaning process will actively search for errors in a
planned way.Evaluation of the implementation strategy
We will use data from the CRT database and will also
conduct a self-administered semi-structured survey of
CHWs, semi-structured interviews with key stakeholders,
and a survey of HPV+ women. RE-AIM and CFIR frame-
works will guide the implementation evaluation (Table 2).
The CFIR comprises 39 common constructs from pub-
lished implementation frameworks and models and orga-
nizes these into five major domains [31]. In this study we
will analyze the following domains: intervention charac-
teristic (relative advantage, adaptability, complexity, cost);
outer setting (patient needs and resources, external po-
licies, incentives); inner setting (structural characteristics,
tension for change, relative priority and available re-
sources, access to knowledge and information); and cha-
racteristics of individuals (knowledge and beliefs about the
intervention, perceived self-efficacy) [31].
Eight weeks after the CRT (intervention and measure-
ment of primary outcome) is finished we will hold a work-
shop as a closing activity to present preliminary results to
CHWs and health authorities. During this workshop,
CHWs will be asked to complete an anonymous,
self-administered semi-structured survey to evaluate their
perspectives and acceptability of the intervention (see out-
comes and qualitative evaluation in Table 2), and about
barriers and facilitators of the intervention. We will
administer the survey during the closing activity to assure
a high response rate. Project staff members will emphasize
that participation in the survey is anonymous and volun-
tary; all participating CHWs will sign consent forms.
Those CHWs who are not able to attend this closing
Table 2 Measurements and data sources proposed for the implementation evaluation based on RE-AIM and CFIR
Quantitative outcomes Qualitative evaluation Data source
Reach: representativeness of
women reached by the
intervention (quantitative data)
% of eligible women who




CRT database (Trial form)
Effectiveness in increasing
women’s adherence to triage
(quantitative and qualitative
data)
Primary outcome: percentage of
women with triage smears 120






Adoption by CHWs of the
strategy of visiting HPV+ women




% of CHWs that visited at least
one HPV+ woman after receiving
the SMS message and e-mail




and beliefs about the intervention;
perceived self-efficacy







activities according to protocol
(quantitative data)
Acceptability of the intervention
by women (quantitative and
qualitative data)
Barriers and facilitators to
implementing and administering
the intervention (qualitative data)
% of randomized CHWs that
participated in training
% of SMS messages that reached a
valid phone number
% of e-mails that reached a valid
e-mail address
% of CHWs who sent confirmatory
e-mails
% of women who accept and are
satisfied with the intervention
Woman level: experience and perception
of the intervention; acceptability of SMS
messages, pertinence of frequency,
reception time, and content of SMS messages
Stakeholder/CHW level: CFIR constructs:
relative advantage; adaptability; complexity
and cost. patient needs and resources and
external policies and incentives
Structural characteristics; tension for change,
relative priority and available resources,
access to knowledge and information
Automated Messaging
System Monitoring Registry







Maintenance Intention to incorporate the strategy Interview with stakeholders
CFIR Consolidated Framework for Implementation Research, CHW community health worker, CRT cluster randomized trial, HPV human papillomavirus, RE-AIM
Reach, Effectiveness, Adoption, Implementation, and Maintenance, SITAM national screening information system
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requested to send it to project staff in a blind envelope.
In the third year of the project we will conduct
semi-structured interviews with stakeholders to evaluate
their acceptability of the intervention and perspectives
on how to build and enhance project sustainability (see
qualitative evaluation in Table 2). Invited stakeholders
will include directors and intermediate coordinators of
the Minister and Secretaries of Health (the PHC Direc-
tion, the provincial Program on Cervical Cancer Preven-
tion, etc.), and heads of gynecology services, and of the
HPV laboratory. Constructs to be considered in the
script will include: relative advantage, adaptability, com-
plexity and cost; patient needs and resources, and exter-
nal policies and incentives; structural characteristics;
tension for change; relative priority; available resources;
access to knowledge and information. Interviews with
health authorities will also include questions to evaluate
the potential for programmatic incorporation of the
multi-component mHealth intervention to measure the
maintenance dimension of RE-AIM. The sample size
will be determined based on relevance and theoretical
saturation [48]. We will select participants to guarantee
that a wide range of responses is captured and to allow
comparisons between them. To ensure we include
enough stakeholders from relevant groups, we planto conduct at least 20 interviews. With prior
authorization of the participants, each interview will
be audio-recorded.
Finally, we will carry out a structured questionnaire
among all HPV+ women from the MH group (Women
Survey) to evaluate their acceptability of the strategy,
their perspectives about the implementation, and rea-
sons for adherence and nonadherence to triage. All HPV
+ women from the CRT intervention group (approxi-
mately 240 women) will be surveyed 5 months after their
HPV test result (i.e., 1 month after measurement of the
primary outcome), irrespective of their triage status. The
questionnaire will include open and closed questions with
dimensions related to women’s experiences and percep-
tions, including acceptability and relevance of SMS mes-
sage frequency, receipt time, and content, the perceived
effect of the multiple components of the intervention on
their adherence, and reasons for adhering/not adhering to
triage. The nominated list of these women and their con-
tact details will be extracted from the CRT database.
Trained interviewers will contact these women via tele-
phone to make a home appointment to administer the
questionnaire. The interviewers will be trained by the pro-
ject staff; training will include formal aspects regarding
applying the questionnaire as well as skills for developing
a connection with the interviewees.
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Quantitative data analysis A descriptive analysis of each
study dimension will be carried out using frequencies and
percentages for each of the different survey variables. Out-
comes will be compared across CHW sociodemographic
characteristics using logistic regression and across women
using generalized mixed linear models. Results will be pre-
sented as estimates and 95% confidence intervals. Analysis
will be conducted using STATA v. 14.0 and/or SAS v. 9.4.
Qualitative data analysis We will use CFIR as an orga-
nizing and analytic framework for Aim 2. We will use an
iterative approach to analyzing qualitative data. Researchers
will read, interpret, and identify themes and subthemes
from data to develop a codebook [49]. To ensure coding
reliability, two researchers will independently code all the
interview transcripts. They will hold regular discussions to
resolve disagreements and reach consensus, and will dis-
cuss uncertainties with a third team member (a specialist in
qualitative research). After coding, thematic and content
analysis will be conducted. We will use Atlas.ti to organize,
analyze, and summarize common themes across types of
participants.
Discussion
The ATICA study is a cutting-edge multi-component
mHealth intervention that combines mHealth technologies
and primary health care to increase the effectiveness of CC
prevention programs. The majority of the mHealth deve-
lopments have targeted health problems such as hyperten-
sion, diabetes, tuberculosis, and HIV-AIDS [13–19]. To the
best of our knowledge no previous use of these technolo-
gies in HPV self-collection screening programs has been
published. By combining an mHealth intervention with
CHW outreach we aim to improve adherence to triage,
increase the effectiveness of the self-collection intervention,
and accelerate reduction of disease burden. Key conside-
rations of our study design include embedding the
intervention in the existing health system, and conduc-
ting a pragmatic trial under programmatic conditions
using existing human resources not requiring a com-
plex reorganization of the CC prevention program
already in place.
Combining mHealth technology with CHW outreach
for CC prevention is also highly innovative. Using an auto-
mated system for communicating the availability of results
immediately is a novel approach to inform HPV+ women
about results because it reduces delay in result delivery
and reinforces trust in the health system. Reminders will
minimize forgetfulness, especially when women are busy
with work or are away from home [50–52]. In addition,
the proposed mHealth intervention will reinforce the pri-
vileged link that CHWs have with their communities topromote health information and behaviors. Despite being
automated, these interventions are perceived to provide
social support and reflect the concern of the health care
providers [51]. Thus, mHealth technologies can facilitate
and strengthen the relationship between CHWs and com-
munity women, creating a health-promoting environment.
Furthermore, by prompting CHWs with SMS and email
messages to make in-person visits to nonadherent HPV+
women, this intervention will provide a tailored compo-
nent of social support to address barriers. The implemen-
tation evaluation will further show how an intervention
can be planned, fielded, and evaluated using implementa-
tion science frameworks and tools, which is novel in LAC
and in the CC prevention literature.
This study has several potential limitations. First, there
is risk for contamination due to assigning CHWs who
work in neighboring areas to different study groups, which
could activate CHWs and women in the UC group. How-
ever, our prior work using CHW cluster randomization
[25] suggests that this risk is low, and the effect of con-
tamination is minimal. If such an effect occurs, we expect
them to be moderate since meaningful improvements in
adherence to triage require a systematic effort to address
problems related to follow-up adherence which are un-
likely to occur in the absence of a specific intervention.
Second, it is not possible to blind the CHWs (clusters) or
women in this study. However, the assessment of primary
and secondary outcomes will be objective, as data on
triage is extracted from SITAM. Third, there is potential
for attrition due to poor cell phone network coverage or
reception or gaps in the service. However, power calcula-
tions accounted for this type of attrition.
The results of this study will inform local and regional
health systems and screening programs on the implemen-
tation of automated messaging systems to increase triage.
If the intervention is effective, it could also be scaled-up to
deliver results for clinician-collected HPV tests. Thus, the
study design and approach can serve as a model of work,
constituting an important advance in the use of implemen-
tation science in the region and for the field of cancer
prevention. Ultimately, improved results delivery and in-
creased triage adherence will increase the impact of HPV
self-collection and help reduce unnecessary CC deaths.
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